Thursday, 16 January 2025

A benign review of a malignant past

The shifting feasts of consulting

This was my third outing of the week after church on Sunday and the office on Tuesday. I had a rescheduled appointment from December that I attended yesterday. It was my usual biannual checkup, which has shifted from the April/October cycle to a January/July cycle in three years.

Once I realised, I would not be able to attend the early December appointment because I would be out of the country, I called to postpone the appointment and reschedule it to mid-January. I ensure I never miss my hospital appointments or consultations as it deprives others of time and audience with scarce medical personnel.

A miscommunication between us some 18 months ago meant I never received my expected scheduling for May, and we fell into a June/December cycle that only happened once. Besides rescheduling, I was promptly given a prescription to make up for the additional time.

Let’s keep to what we discussed

For this consultation, I had a few issues to discuss, the main one being the unfortunate mismanagement of information that I should not have received until I had met the consultant involved in that area of investigation and diagnosis. The computerisation of personal medical records meant that a certain diagnosis ended up in my clinic notes that the person I met should have redacted before forwarding to my doctor and I.

Blog - The note that crept in

The sinking feeling of reading a diagnosis of adenocarcinoma of prostate over a week before my scheduled appointment with the consultant urologist was as earth-shattering as it was a humbling reminder of one’s mortality. When I remonstrated with the doctor, he offered to redact the diagnosis, but what good was bolting the doors after the horses had bolted?

Meeting with the chief consultant of the team that had assumed my care for over a decade and she for about 8 years, she immediately understood the issue.

She said she would raise an incident with the multidisciplinary teams to ensure that they are aware of what information gets passed to the patient; that it is centred on their particular consultations; and that the more interested patients can assess seemingly hidden interdepartmental communications to read the chatter pertaining to them.

A malignant test of the benign

For me, what I learnt was the difference between the definition of malignant to the layperson and the medical establishment. When I read malignant adenocarcinoma of the prostate in interdepartmental communications, I read it as a qualifier of the type of cancer, something rampaging and very likely to cause death.

To the medical eye, malignant always means cancer regardless of stage or metastasis. The absence of cancer in the presence of a growth or tumour will be considered benign. [Medical News Today: What are the different types of tumour?]

My consultant patiently explained the terms fully to enhance my understanding. Other issues in my notes were from the perspective of the person I saw. Any similarities would suggest a lazy engagement, as situations and circumstances do change between visits.

All good and nice

We discussed the readings of my blood tests, and the need for new assays, though this time without a urine sample and at the end of my allotted time with a medical student present, I was handed on to the phlebotomist who had no problem drawing three vials of blood before I was sent on my way to collect my renewed prescription and I made my way home.

In all, the consultation was pleasant, and the typical readings were within normal range, it is likely I have lost a centimetre in height, and the physiotherapy to address issues in my spine will not commence until all the other medical issues are resolved.

No comments:

Post a Comment

Comments are accepted if in context are polite and hopefully without expletives and should show a name, anonymous, would not do. Thanks.